COVID-19: Page 4

Masking should continue in healthcare settings, some experts say

By Elissa Wolfson

Masking in healthcare settings should continue in order to optimize patient safety, recommend infectious disease experts in a commentary.

May 16, 2023

LumiraDx Q1 revenues drop 82% as its transition from non-COVID tests takes shape

By LabPulse.com staff writers

In April, the company had announced a cost restructuring program involving a reduction of its global workforce by approximately 40%. It now expects to see the full impact of the restructuring activities during the third quarter.

May 16, 2023

A closer look at long COVID symptoms

By Elissa Wolfson

Intensively studied patients with persistent post-COVID neurological symptoms were found to have autonomic dysfunction and differences in their immune cell profiles.

May 10, 2023

FDA grants de novo request enabling the marketing of QuidelOrtho SARS-CoV-2 antibody tests

By LabPulse.com staff writers

The tests are intended for prescription use only for the qualitative detection of IgG antibodies to SARS-CoV-2 to aid in identifying patients who have an adaptive immune response to SARS-CoV-2 from either a recent or prior infection.

May 10, 2023

Siemens Healthineers Q2 diagnostics revenues drop 39% on decline in rapid antigen test sales

By Leo O'Connor

The firm is seeing a return to low- to mid-single digital revenue growth as swings in demand from COVID-19 testing to routine testing normalize, Sharon Bracken, its president of diagnostics, said in an interview.

May 10, 2023

Quest Diagnostics outlines changes to IVD landscape with end in sight for U.S. public health emergency

By LabPulse.com staff writers

Some retail testing -- at pharmacies, for example -- may not be available and patient-initiated testing may not be covered, Quest said.

May 8, 2023

AI in study enables better RT-LAMP, CRISPR tests

By Elissa Wolfson

Artificial intelligence, CRISPR, and RT-LAMP technologies are helping developers create simple, reliable tests for hepatitis C and COVID-19 for eventual at-home use.

May 8, 2023

Heart injury biomarker may help COVID-19 patients avoid hospitalization

By Elissa Wolfson

Researchers found that measuring blood levels of cardiac troponin, a heart injury biomarker, may help COVID-19 patients avoid hospitalization.

April 25, 2023

DOJ brings criminal charges alleging COVID-19 fraud, false billings exceeding $490M

By LabPulse.com staff writers

DOJ charged a lab owner, OTC test suppliers, and others with a variety of COVID-19-related scams.

April 21, 2023

Point-of-care IVD sales rose to $45 billion in 2022

By Bruce Carlson

Numerous trends will combine to enable a growing market. According to the Kalorama report, growth of 3.3% per year is expected over the forecast period from 2022 to 2027.

April 19, 2023

Abbott Q1 diagnostics sales decline, but CEO sees milder impact from pandemic

By Leo O'Connor

The impact of COVID-19 on its overall business “has rapidly and significantly lessened,” according to Abbott Chairman and CEO Robert Ford.

April 19, 2023

Study of more than 600,000 people links COVID-19 infection to increase in diabetes diagnoses

By Nick Paul Taylor

The analysis, details of which were published in JAMA Network Open, looked at 629,935 people, 503,948 of whom tested negative for COVID-19.

April 18, 2023

Previous Page

Page 4 of 34

Next Page